(A) Western blot for YAP, TAZ, and actin levels in the indicated CRISPR-mediated knockout (KO) strains and the parental cell line (CTRL). (B) Relative growth in low attachment conditions of the …
(A) Western blot for the indicated proteins (STAT3-p, a form phosphorylated at Tyr705) in cells treated with the indicated siRNAs for 24 hr and then with TAM for the indicated times. (B) Normalized …
RNA levels of YAP, TAZ, STAT3, and NF-κB1 in non-transformed (ETH) or transformed (TAM) cells knocked down by siRNA (i) of the indicated factors.
(A) Levels of the indicated proteins in the indicated fractions in non-transformed (E; ethanol) and transformed (T; tamoxifen) conditions: MEK1/2, cytoplasm marker; U1 SnRNAP70, nucleoplasm marker; …
(A) Levels of the indicated proteins in the cytoplasm or nucleus of non-transformed (E) or transformed (T) cells. LDH-A is a cytoplasm marker and H3 is a nucleus marker. (B) Levels of the indicated …
(A) Correlation (r ~ 0.7) of YAP and TAZ binding signals in non-transformed (ETH) and transformed (TAM) cells. Putative YAP- and TAZ-specific sites are indicated, respectively, as green and yellow. …
Enrichment of the indicated motifs (different colors) in STAT3, JUNB, TEAD, and TAZ-specific (i.e., not bound by YAP) binding sites when compared with matched control DNase-hypersensitive regions in …
(A) Heatmaps indicate ChIP-seq signals of the indicated proteins for YAP/TAZ peaks arrayed from top to bottom in decreasing YAP ChIP signal. (B) Distance between peak summits for biological …
(A) Heatmaps indicate ChIP-seq signals of YAP, TAZ, TEAD, JUNB, and STAT3 for YAP/TAZ peaks arrayed from top to bottom in decreasing YAP ChIP signal. (B) Distance between peak summits for biological …
(A) Percent of binding regions for the indicated proteins that contain a given DNA sequence motif. (B) Enrichment and p-values for various motifs within YAP/TAZ target sites in transformed cells as …
(A) Heatmaps indicate ChIP-seq signals of indicated proteins for YAP/TAZ peaks arrayed from top to bottom in decreasing YAP ChIP signal. (B) Correlation between YAP and TAZ binding levels, with …
(A) Percent of binding regions for the indicated proteins that contain a given DNA sequence motif (different colors). (B) Enrichment of motifs within YAP/TAZ binding sites as compared with control …
(A) Overlap between genes with decreased or increased expression in transformed cells treated with RNAi against YAP, TAZ, STAT3, or JUNB when compared with a control RNAi. (B) Heatmap illustrates …
Correlation between (A) biological replicates and (B) number of binding sites of the indicated proteins in ER-Src ethanol or tamoxifen; wild-type and YAP or TAZ knockout (KO) and MDA-MB-231 cells.
Enriched GO categories for YAP-specific, TAZ-specific, or shared YAP/TAZ target genes.
Gene signatures for the indicated categories of YAP/TAZ target sites.
Enriched GO terms with associated q-values for genes with YAP/TAZ target sites containing only AP-1, TEAD, or STAT motif but not combinations of motifs.
siRNAs, antibodies, qPCR primers, ChIP-seq primers, and list of datasets.